Supply chains have been a big topic in the news lately. That’s because these integral elements of global trade are how we transport our goods. When they’re disrupted, the results are bad for businesses and consumers alike. Fortunately, however, innovations in logistics tech are helping to stabilize supply chains worldwide.
One of the biggest obstacles we face in making the transition to clean energy sources is storage. Harnessing the power of renewable energy sources is one thing, but it’s quite another to store that energy away for long periods. Of course, resolving Read more […]
For the first time, a session on cooperation with Europe, organized with the assistance of the Association of European Businesses: “Russian-European Relations Today and Tomorrow: Challenges and Opportunities for Business” was held on the margins of SPIEF-2019.
LOFAR (Low Frequency Array) is the world’s largest and most sensitive low frequency radio telescope. It was designed, built, and is now operated by ASTRON, the Netherlands Institute for Radio Astronomy. LOFAR’s reach now spans Europe – from Ireland to Poland, with the newest LOFAR antenna station being delivered to Ventspils University of Applied Sciences in Latvia. Here we propose that LOFAR is a prime example of how state-of-the-art facilities leads to the sharing and building of competencies and innovation: it is one of today’s major success stories of research infrastructures on a European scale.
EuroScientist is off for a summer break! In the meantime, help us sign and spread the petition to double the EU Budget for Research and Innovation compared to Horizon 2020. The #DoubleRIEU petition is an initiative from EuroScience and Initiative for Science in Europe.
The term ‘value’ is at the centre of an increasingly explicit debate in the fields of health and healthcare policy. ‘Value’ is understood in many different ways and diverging interests are being mobilised. How are values in biomedical innovation being expressed, represented, materialised and aligned or contested in different areas of biomedicine? How do values embedded in regulation, public health, economic policies, healthcare provision, technology assessment, producers’ strategies, and patient organisation movements shape biomedical innovations? At an ESOF discussion in Toulouse multidisciplinary perspectives on value between panel members and public participants will be explored and possible pathways to common solutions identified that promote socially acceptable biomedical innovation in the European context.
European science conversations by the community, for the community
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.